Pharmaceutical Executive September 25, 2023
Mike Hollan

Cleve talks about the future of the industry and how data remains a key focus.

New technologies are changing the ways that life sciences and regulatory agencies approach the collection and analysis of data. Scott Cleve, vice president of regulatory operations, information, and compliance at Daiichi Sankyo sat down with Pharm Exec at the Veeva R&D and Quality Summit 2023 in Boston to discuss these topics.

Pharm Exec: What are the current struggles with the regulatory environment right now?

Scott Cleve: For regulatory, we are so focused with understanding the regulations for delivering our products to market and working with FDA. For us, that’s dictated by FDA requirements and guidance, which are more scientific in nature. Those change from time...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Conferences / Podcast, FDA, Govt Agencies, Interview / Q&A, Pharma / Biotech, Trends
GPUs go biological: BBB unveils Bionode, lab-grown, living neuron compute for AI applications
The Download: speaking to robots, and growing pharmaceutical mushrooms
Sofinnova closes new fund and backs a trio of new biotechs
AstraZeneca's $1 Billion Deal Highlights Growing Interest in In Vivo Cell Therapies
Pharmacists Play Key Role in Supporting Patients Using GLP-1s

Share This Article